EyePoint, Inc. Cash and Restricted Cash
EyePoint, Inc. (EYPT) had Cash and Restricted Cash of $110.61 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $110.61M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $77.86M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $101.97M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $74.73M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $110.61M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $77.86M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $101.97M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $74.73M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $71.29M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $85.31M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $99.85M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $79.98M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $90.92M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $271.16M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $281.41M 10-K · filed 2026-03-05 |
| 2023-09-30 | $133.19M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $139.75M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $105.92M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $95.78M 10-K · filed 2025-03-06 |
| 2022-09-30 | $75.51M 10-Q · filed 2023-11-03 |
| 2022-06-30 | $82.28M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $101.69M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $178.74M 10-K · filed 2024-03-08 |
| 2021-09-30 | $119.86M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $127.78M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $138.73M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $45.06M 10-K · filed 2023-03-10 |
| 2020-09-30 | $28.88M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $22.96M 10-Q · filed 2021-08-06 |
| 2020-03-31 | $26.45M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $22.36M 10-K · filed 2022-03-14 |
| 2019-09-30 | $31.91M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $44.31M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $43.53M 10-Q · filed 2020-05-08 |
| 2018-12-31 | $45.41M 10-K · filed 2021-03-12 |
| 2018-09-30 | $55.91M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $38.93M 10-K · filed 2020-03-16 |
| 2018-03-31 | $16.50M 10-Q · filed 2019-05-10 |
| 2017-12-31 | $13.03M 10-Q · filed 2019-11-07 |
| 2017-09-30 | $11.98M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $17.05M 10-K · filed 2020-03-16 |
| 2016-06-30 | $15.46M 10-K · filed 2020-03-16 |
| 2015-06-30 | $19.27M 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |